$75.23
+0.580 (+0.777%)
At Close: Jun 03, 2026
ANI Pharmaceuticals: A Rare GARP Stock In An Overbought Market
04:01am, Friday, 11'th Oct 2024
Today, we revisit small biopharma ANI Pharmaceuticals, as it is a GARP stock trading near technical support, with solid growth prospects. The company recently acquired Alimera Sciences for $380 millio
Wall Street Analysts Predict a 42.98% Upside in ANI (ANIP): Here's What You Should Know
10:56am, Wednesday, 09'th Oct 2024
The consensus price target hints at a 43% upside potential for ANI (ANIP). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisi
Are Investors Undervaluing ANI Pharmaceuticals (ANIP) Right Now?
10:46am, Friday, 27'th Sep 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
ANI Pharmaceuticals Announces the FDA Approval and Launch of Ketoconazole Shampoo, 2%
06:50am, Thursday, 26'th Sep 2024
PRINCETON, N.J., Sept. 26, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that following final approval from the U.S. Food and Drug Administrati
ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences
08:53am, Monday, 16'th Sep 2024
PRINCETON, N.J., Sept. 16, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or “the Company”) (Nasdaq: ANIP) today announced the completion of its previously announced acquisition of
ANI Pharmaceuticals Initiates Closing of Acquisition of Alimera Sciences
06:50am, Monday, 16'th Sep 2024
PRINCETON, N.J., Sept. 16, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (“ANI” or the “Company”) announced today that the Company has initiated closing logistics for the p
ANI Pharmaceuticals Launches Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution
06:50am, Friday, 13'th Sep 2024
PRINCETON, N.J., Sept. 13, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Promethazine Hydrochloride and Dextromethorphan Hydrob
ANI Pharmaceuticals and Alimera Sciences Announce Closing Date of Merger
06:50am, Wednesday, 11'th Sep 2024
PRINCETON, N.J. and ATLANTA, Sept.
ANI Pharmaceuticals Provides Update on Closing of Acquisition of Alimera Sciences
02:09pm, Tuesday, 10'th Sep 2024
PRINCETON, N.J., Sept. 10, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or “the Company”) (Nasdaq: ANIP) today provided an update on the status of the completion of its previously
Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?
10:47am, Thursday, 15'th Aug 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
PRINCETON, N.J., Aug. 13, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the closing of its offering of $316,250,000 aggregate principal amount
ANI Pharmaceuticals, Inc. (ANIP) Q2 2024 Earnings Call Transcript
12:40pm, Friday, 09'th Aug 2024
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP ) Q2 2024 Earnings Conference Call August 6, 2024 8:30 AM ET Company Participants Lisa Wilson - IR Nikhil Lalwani - President, CEO & Director Christopher Mutz -
ANI Pharmaceuticals, Inc. Prices Upsized $275.0 Million Convertible Senior Notes Offering
09:44pm, Wednesday, 07'th Aug 2024
PRINCETON, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the pricing of its offering of $275,000,000 aggregate principal amount
ANI Pharmaceuticals, Inc. Announces Proposed Convertible Senior Notes Offering
07:00am, Wednesday, 07'th Aug 2024
PRINCETON, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced its intention to offer, subject to market and other conditions, $250,00
Compared to Estimates, ANI (ANIP) Q2 Earnings: A Look at Key Metrics
11:00am, Tuesday, 06'th Aug 2024
The headline numbers for ANI (ANIP) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and
Sign In
Buy ANIP